KEL1 negative red cell transfusions for females of current or future child‐bearing potential: A clinical impact and feasibility study
Sign Up to like & getrecommendations! Published in 2022 at "Transfusion"
DOI: 10.1111/trf.17201
Abstract: Anti‐K is an alloantibody stimulated in response to the KEL1 antigen and may cause hemolytic disease of the fetus and newborn (HDFN). Provision of KEL1 negative blood to females of child‐bearing potential was not our… read more here.
Keywords: kel1 negative; negative red; impact; feasibility ... See more keywords